Comparative dynamics of four smoking withdrawal symptom scales.
暂无分享,去创建一个
[1] M. Fiore,et al. Smoking withdrawal dynamics in unaided quitters. , 2000, Journal of abnormal psychology.
[2] H. Javitz,et al. The dynamics of the urge-to-smoke following smoking cessation via pharmacotherapy. , 2011, Addiction.
[3] Smoking withdrawal dynamics: I. Abstinence distress in lapsers and abstainers. , 2003 .
[4] S. Shiffman,et al. The relevance and treatment of cue-induced cravings in tobacco dependence. , 2009, Journal of substance abuse treatment.
[5] D. Conti,et al. Nicotinic acetylcholine receptor β2 subunit gene implicated in a systems-based candidate gene study of smoking cessation , 2008, Human molecular genetics.
[6] K. Conneely,et al. The Galanin Receptor 1 Gene Associates with Tobacco Craving in Smokers Seeking Cessation Treatment , 2011, Neuropsychopharmacology.
[7] Timothy B Baker,et al. Life before and after quitting smoking: an electronic diary study. , 2006, Journal of abnormal psychology.
[8] L. Epstein,et al. Role of Functional Genetic Variation in the Dopamine D2 Receptor (DRD2) in Response to Bupropion and Nicotine Replacement Therapy for Tobacco Dependence: Results of Two Randomized Clinical Trials , 2006, Neuropsychopharmacology.
[9] S Shiffman,et al. A day at a time: predicting smoking lapse from daily urge. , 1997, Journal of abnormal psychology.
[10] J. Cappelleri,et al. Revealing the multidimensional framework of the Minnesota nicotine withdrawal scale , 2005, Current medical research and opinion.
[11] M. Fiore,et al. Smoking withdrawal dynamics: III. Correlates of withdrawal heterogeneity. , 2003, Experimental and clinical psychopharmacology.
[12] H. Aubin,et al. Craving's place in addiction theory: Contributions of the major models , 2010, Neuroscience & Biobehavioral Reviews.
[13] L. Epstein,et al. Toward Personalized Therapy for Smoking Cessation: A Randomized Placebo‐controlled Trial of Bupropion , 2008, Clinical pharmacology and therapeutics.
[14] Megan E. Piper,et al. Human neuronal acetylcholine receptor A5-A3-B4 haplotypes are associated with multiple nicotine dependence phenotypes. , 2009, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.
[15] Megan E. Piper,et al. Tobacco withdrawal components and their relations with cessation success , 2011, Psychopharmacology.
[16] C. Lerman,et al. Nicotine metabolite ratio predicts efficacy of transdermal nicotine for smoking cessation , 2006, Clinical pharmacology and therapeutics.
[17] Thomas R. Kirchner,et al. Cigarette-by-cigarette satisfaction during ad libitum smoking. , 2009, Journal of abnormal psychology.
[18] J. Etter,et al. A comparison of the psychometric properties of three cigarette withdrawal scales. , 2006, Addiction.
[19] Thomas H. Brandon,et al. The early time course of smoking withdrawal effects , 2006, Psychopharmacology.
[20] Yantao Zuo,et al. Neurotransmission-related genetic polymorphisms, negative affectivity traits, and gender predict tobacco abstinence symptoms across 44 days with and without nicotine patch. , 2009, Journal of abnormal psychology.
[21] S S Smith,et al. Development and validation of the Wisconsin Smoking Withdrawal Scale. , 1999, Experimental and clinical psychopharmacology.
[22] Christina N. Lessov-Schlaggar,et al. Association of tobacco dependence and quit attempt duration with Rasch-modeled withdrawal sensitivity using retrospective measures. , 2009, Addiction.
[23] Megan E. Piper,et al. Addiction motivation reformulated: an affective processing model of negative reinforcement. , 2004, Psychological review.
[24] J. Hughes,et al. Effects of abstinence from tobacco: valid symptoms and time course. , 2007, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.
[25] Timothy B Baker,et al. Smoking withdrawal dynamics: II. Improved tests of withdrawal-relapse relations. , 2003, Journal of abnormal psychology.